Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Sodium chloride
Drug ID BADD_D02473
Description Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines.
Indications and Usage This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
Marketing Status approved; vet_approved
ATC Code A12CA01; B05CB01; B05XA03
DrugBank ID DB09153
KEGG ID D02056
MeSH ID D012965
PubChem ID 5234
TTD Drug ID D04YZL
NDC Product Code 76420-083; 80327-011; 82529-000; 10106-3301; 81861-0026; 82056-0001; 24208-277; 42829-001; 46163-300; 51662-1258; 51879-122; 52584-888; 52584-966; 57826-441; 0338-0160; 63323-093; 63323-187; 63323-632; 63323-924; 65219-222; 0409-1141; 69842-284; 0536-1254; 70529-022; 70529-049; 71872-7084; 79672-613; 80762-0010; 81826-001; 24600-1386; 17271-700; 24208-385; 52584-186; 0264-1800; 0264-2201; 0264-5804; 0264-7805; 0338-9151; 65219-472; 65282-1505; 65282-1510; 0404-9953; 69842-285; 70529-136; 70795-1120; 71872-7248; 76297-001; 80762-0012; 24600-1138; 0990-7730; 11822-0470; 49230-300; 0220-3593; 0220-3597; 0220-3599; 54973-4080; 59390-183; 0338-0047; 63323-623; 65219-226; 65219-468; 65219-474; 0404-9955; 68428-885; 70369-007; 70369-010; 54973-6433; 0338-0054; 62106-5206; 63323-090; 63323-186; 0363-5558; 0363-7500; 65219-470; 0409-1966; 0536-1253; 0641-6144; 73666-0580; 77267-007; 80771-000; 0990-7138; 55579-937; 17478-622; 50090-2488; 0220-3598; 51662-1577; 0264-7802; 58264-0135; 0338-0050; 0338-0051; 0338-0182; 0338-0553; 0338-9543; 0363-1505; 63323-088; 64117-867; 65219-220; 65219-230; 65219-232; 0404-9978; 80327-009; 11014-0075; 24874-0001; 49452-6690; 49452-6700; 0990-7983; 11822-0469; 17271-701; 42829-505; 51662-1318; 0264-7800; 0264-9375; 54973-4095; 55681-305; 0338-0186; 0338-0192; 63323-095; 63323-626; 0363-9050; 0409-4888; 0409-7101; 71872-7083; 73666-0550; 73666-0560; 73666-0570; 14639-6444; 70343-210; 70387-109; 11822-5458; 42829-003; 51662-1464; 0264-7806; 55154-4358; 0338-0162; 0338-0166; 63323-530; 65219-466; 0487-4301; 69626-0064; 69842-533; 70529-021; 76328-100; 10695-153; 24208-276; 0220-3586; 0220-3590; 51662-1342; 51879-191; 0264-5802; 55910-632; 0338-0056; 0338-9159; 65219-218; 65219-432; 67091-327; 70529-024; 71309-154; 0641-0497; 76472-1154; 76472-4096; 77333-835; 77333-844; 0990-6138; 51552-0077; 0990-7972; 0990-7985; 55154-9357; 0338-0048; 0338-0049; 59779-303; 63323-099; 0363-5557; 65219-224; 65219-228; 68428-061; 69842-473; 70529-023; 71872-7082; 0641-1512; 76472-4026; 80762-0011; 10106-3302; 24600-1382; 63822-0001; 51662-1522; 0363-0193; 62106-1058; 63323-139; 64253-202; 0404-9954; 68428-111; 68428-526; 0409-6660; 69842-472; 0990-7984; 69500-110; 70387-115; 17478-623; 42829-407; 42829-504; 49281-912; 0019-1188; 0220-3595; 0220-3600; 52584-109; 55154-0126; 58657-118; 0338-0043; 0338-0164; 0338-0196
UNII 451W47IQ8X
Synonyms Sodium Chloride | Sodium Chloride, (22)Na | Sodium Chloride, (24)NaCl
Chemical Information
Molecular Formula ClNa
CAS Registry Number 7647-14-5
SMILES [Na+].[Cl-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Uterine cancer16.12.05.001; 21.07.02.003--Not Available
Uterine leiomyoma21.07.02.004; 16.04.02.001--Not Available
Vein disorder24.03.02.015--Not Available
Venous thrombosis24.01.01.008--Not Available
Ventricular fibrillation02.03.04.0080.000603%
Ventricular tachycardia02.03.04.0100.000362%
Vision blurred17.17.01.010; 06.02.06.007--
Visual acuity reduced17.17.01.011; 06.02.10.012--
Visual field defect17.17.01.001; 06.02.07.0030.000241%Not Available
Visual impairment06.02.10.013--Not Available
Vomiting07.01.07.0030.008641%
Wheezing22.03.01.0090.000845%
Mental status changes19.07.01.0010.000845%Not Available
Mobility decreased08.01.03.030; 15.03.05.023; 17.02.05.018--Not Available
Multiple sclerosis relapse17.16.01.003--Not Available
Cardiotoxicity02.11.01.009; 12.03.01.0070.000241%Not Available
Poor venous access24.03.02.017--Not Available
Hypoacusis04.02.01.0060.000362%
Brain oedema17.07.02.003; 12.01.10.0100.000362%
General physical health deterioration08.01.03.018--Not Available
Quadriparesis17.01.04.0120.000483%Not Available
Left ventricular hypertrophy02.04.02.0140.000241%Not Available
Muscle tightness15.05.03.007--Not Available
Balance disorder08.01.03.081; 17.02.02.007--Not Available
Dysstasia15.03.05.011; 08.01.03.089; 17.02.02.012--Not Available
Intervertebral disc protrusion15.10.01.004--Not Available
Musculoskeletal chest pain22.09.01.001; 15.03.04.012--
Self-injurious ideation19.12.01.007--Not Available
Facial paresis17.04.03.0020.000241%
Central nervous system lesion17.02.10.011--Not Available
The 13th Page    First    Pre   13 14 15 16 17    Next   Last    Total 17 Pages